Similar articles

• Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

  Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group. Bergenstal RM, et al. N Engl J Med. 2010 Jul 22;363(4):311-20. doi: 10.1056/NEJMoa1002853. Epub 2010 Jun 29. N Engl J Med. 2010. PMID: 20587585 Clinical Trial.
• [Insulin pump with glucose sensor in type 1 diabetes. But the artificial pancreas is still far off].

  Moberg E. Moberg E. Lakartidningen. 2010 Dec 8-14;107(49):3120-1. Lakartidningen. 2010. PMID: 21284143 Swedish. No abstract available.
• Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.

  Jeandidier N, Pinget M, Keipes M, Louy S, Vetter A, Réville P. Jeandidier N, et al. Transplant Proc. 1992 Jun;24(3):948-9. Transplant Proc. 1992. PMID: 1604678 Clinical Trial. No abstract available.
• Nighttime continuous subcutaneous insulin infusion revisited: a strategy for improving insulin delivery.

  Schiffrin A. Schiffrin A. Diabetes Care. 2000 May;23(5):571-3. doi: 10.2337/diacare.23.5.571. Diabetes Care. 2000. PMID: 10834409 Review. No abstract available.
• [The diabetic child and the specifics of insulin therapy].

  Dirlewanger M, Perrenoud L, Castellsague-Perolini M, Schwitzgebel VM. Dirlewanger M, et al. Rev Med Suisse. 2007 Apr 18;3(107):994-1000. Rev Med Suisse. 2007. PMID: 17526373 Review. French.